How to Fabricate Hyaluronic Acid for Ocular Drug Delivery

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2025 Jan 8

PMID 39771582

Authors

Martha Kim

Mi-young Jung

Do-Yeon Lee

So Min Ahn

Gyeong Min Lee

Choul Yong Park

Affiliations

Soon will be listed here.

Abstract

This review aims to examine existing research on the development of ocular drug delivery devices utilizing hyaluronic acid (HA). Renowned for its exceptional biocompatibility, viscoelastic properties, and ability to enhance drug bioavailability, HA is a naturally occurring biopolymer. The review discussed specific mechanisms by which HA enhances drug delivery, including prolonging drug residence time on ocular surfaces, facilitating controlled drug release, and improving drug penetration through ocular tissues. By focusing on these unique functionalities, this review highlights the potential of HA-based systems to revolutionize ocular treatment. Various fabrication techniques for HA-based ocular drug delivery systems, including hydrogels, nanoparticles, and microneedles, are discussed, highlighting their respective advantages and limitations. Additionally, this review explores the clinical applications of HA-based devices in treating a range of ocular diseases, such as dry eye syndrome, glaucoma, retinal disorders, and ocular infections. By comparing the efficacy and safety profiles of these devices with traditional ocular drug delivery methods, this review aims to provide a comprehensive understanding of the potential benefits and challenges associated with HA-based systems. Moreover, this review discusses current limitations and future directions in the field, such as the need for standardized fabrication protocols, long-term biocompatibility studies, and large-scale clinical trials. The insights and advancements presented in this review aim to guide future research and development efforts, ultimately enhancing the effectiveness of ocular drug delivery and improving patient outcomes.

References

Serra M, Casas A, Toubarro D, Barros A, Teixeira J . Microbial Hyaluronic Acid Production: A Review. Molecules. 2023; 28(5). PMC: 10004376. DOI: 10.3390/molecules28052084. View

Mochimaru H, Takahashi E, Tsukamoto N, Miyazaki J, Yaguchi T, Koto T . Involvement of hyaluronan and its receptor CD44 with choroidal neovascularization. Invest Ophthalmol Vis Sci. 2009; 50(9):4410-5. DOI: 10.1167/iovs.08-3044. View

Jiang D, Liang J, Noble P . Hyaluronan as an immune regulator in human diseases. Physiol Rev. 2011; 91(1):221-64. PMC: 3051404. DOI: 10.1152/physrev.00052.2009. View

Agrahari V, Mandal A, Agrahari V, Trinh H, Joseph M, Ray A . A comprehensive insight on ocular pharmacokinetics. Drug Deliv Transl Res. 2016; 6(6):735-754. PMC: 5319401. DOI: 10.1007/s13346-016-0339-2. View

Yang Y, Lee W, Kim Y, Hong Y . A Meta-Analysis of the Efficacy of Hyaluronic Acid Eye Drops for the Treatment of Dry Eye Syndrome. Int J Environ Res Public Health. 2021; 18(5). PMC: 7967738. DOI: 10.3390/ijerph18052383. View

Foglarova M, Chmelar J, Huerta-Angeles G, Vagnerova H, Kulhanek J, Barton Tomankova K . Water-insoluble thin films from palmitoyl hyaluronan with tunable properties. Carbohydr Polym. 2016; 144:68-75. DOI: 10.1016/j.carbpol.2016.02.027. View

Crane R, Makia M, Zeibak S, Tebbe L, Ikele L, Woods C . Effective intravitreal gene delivery to retinal pigment epithelium with hyaluronic acid nanospheres. Mol Ther Nucleic Acids. 2024; 35(2):102222. PMC: 11168490. DOI: 10.1016/j.omtn.2024.102222. View

Widjaja L, Bora M, Chan P, Lipik V, Wong T, Venkatraman S . Hyaluronic acid-based nanocomposite hydrogels for ocular drug delivery applications. J Biomed Mater Res A. 2013; 102(9):3056-65. DOI: 10.1002/jbm.a.34976. View

Fallacara A, Baldini E, Manfredini S, Vertuani S . Hyaluronic Acid in the Third Millennium. Polymers (Basel). 2019; 10(7). PMC: 6403654. DOI: 10.3390/polym10070701. View

10.

Awwad S, Abubakre A, Angkawinitwong U, Khaw P, Brocchini S . In situ antibody-loaded hydrogel for intravitreal delivery. Eur J Pharm Sci. 2019; 137:104993. DOI: 10.1016/j.ejps.2019.104993. View

11.

Maulvi F, Soni T, Shah D . Extended release of hyaluronic acid from hydrogel contact lenses for dry eye syndrome. J Biomater Sci Polym Ed. 2015; 26(15):1035-50. DOI: 10.1080/09205063.2015.1072902. View

12.

Chmelar J, Mrazek J, Hermannova M, Kubala L, Ambrozova G, Kocurkova A . Biodegradable free-standing films from lauroyl derivatives of hyaluronan. Carbohydr Polym. 2019; 224:115162. DOI: 10.1016/j.carbpol.2019.115162. View

13.

Kalam M . The potential application of hyaluronic acid coated chitosan nanoparticles in ocular delivery of dexamethasone. Int J Biol Macromol. 2016; 89:559-68. DOI: 10.1016/j.ijbiomac.2016.05.016. View

14.

Zhang T, Abdelaziz M, Cai S, Yang X, Aires D, Forrest M . Hyaluronic acid carrier-based photodynamic therapy for head and neck squamous cell carcinoma. Photodiagnosis Photodyn Ther. 2021; 37:102706. PMC: 8898305. DOI: 10.1016/j.pdpdt.2021.102706. View

15.

Luo Z, Dai Y, Gao H . Development and application of hyaluronic acid in tumor targeting drug delivery. Acta Pharm Sin B. 2019; 9(6):1099-1112. PMC: 6900560. DOI: 10.1016/j.apsb.2019.06.004. View

16.

Solomon S, Lindsley K, Vedula S, Krzystolik M, Hawkins B . Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2014; (8):CD005139. PMC: 4270425. DOI: 10.1002/14651858.CD005139.pub3. View

17.

Laradji A, Karakocak B, Kolesnikov A, Kefalov V, Ravi N . Hyaluronic Acid-Based Gold Nanoparticles for the Topical Delivery of Therapeutics to the Retina and the Retinal Pigment Epithelium. Polymers (Basel). 2021; 13(19). PMC: 8512139. DOI: 10.3390/polym13193324. View

18.

Garrastazu Pereira G, Detoni C, Balducci A, Rondelli V, Colombo P, Guterres S . Hyaluronate nanoparticles included in polymer films for the prolonged release of vitamin E for the management of skin wounds. Eur J Pharm Sci. 2016; 83:203-11. DOI: 10.1016/j.ejps.2016.01.002. View

19.

Yu H, Stephanopoulos G . Metabolic engineering of Escherichia coli for biosynthesis of hyaluronic acid. Metab Eng. 2007; 10(1):24-32. DOI: 10.1016/j.ymben.2007.09.001. View

20.

Singh A, Li P, Beachley V, McDonnell P, Elisseeff J . A hyaluronic acid-binding contact lens with enhanced water retention. Cont Lens Anterior Eye. 2014; 38(2):79-84. PMC: 8407433. DOI: 10.1016/j.clae.2014.09.002. View